Amy L. Burroughs

Insider Reports History

Entity
Individual
Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Amy L. Burroughs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy L. Burroughs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 73.3K $205K $2.80 Jan 3, 2023 Direct
Terns Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (Right to buy) 1.25M Mar 1, 2024 Direct
Terns Pharmaceuticals, Inc. Chief Executive Officer, Director Restricted Stock Unit 150K Mar 1, 2024 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 14.8K Jun 9, 2023 Direct

Insider Reports Filed by Amy L. Burroughs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Chief Executive Officer, Director
TERN Terns Pharmaceuticals, Inc. Feb 7, 2024 0 $0 3 Feb 15, 2024 Chief Executive Officer, Director
TNYA Tenaya Therapeutics, Inc. Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2023 1 $26.2K 4 Jan 3, 2023 Director
TNYA Tenaya Therapeutics, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
TNYA Tenaya Therapeutics, Inc. Dec 5, 2022 0 $0 3 Dec 7, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2022 1 $40K 4 Jan 3, 2022 Director
DMAC DiaMedica Therapeutics Inc. Aug 16, 2021 1 $142K 4 Aug 17, 2021 Director
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 0 $0 3 Jul 16, 2021 Director